Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study

Completed · Not applicable

Conditions studied: Cystic Fibrosis

In brief

Protocol 0000498: Multicenter, open label study to evaluate the effect of sustained RELiZORB (immobilized lipase) cartridge use during enteral feeding on fat absorption, as well as safety and tolerability of sustained RELiZORB use, in patients with cystic fibrosis and exocrine pancreatic insufficiency.

Key facts

Study ID
NCT02750501
Run by
Alcresta Therapeutics, Inc.
People needed
49
Starts
2016-07-20
Expected to finish
2017-03-30
Last updated by the study team
2018-08-15

Who can join

Age: 4 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.